AAREY DRUGS & PHARMACEUTICALS (AAREYDRUGS.BO)

45.79 -0.43 (-0.93%) At close: 03:27PM IST

AAREY DRUGS & PHARMACEUTICALS

107, Sahakar Bhavan
340/348, Narshi Natha Street Narshi Natha Street Masjid Bunder
Mumbai 400009
India
91 22 2345 5543
https://www.aareydrugs.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Description

Aarey Drugs & Pharmaceuticals Limited engages in the manufacture and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company provides mono methyl and die methyl urea, ortho para nitro anisole, 2 bromomethyl 1, and 3 dioxalane and uracile, as well as active pharma ingredients, such as metformin HCL, mefenamic acid, and doxophylline. It also offers chemicals and solvents, including aromatic chemicals, chemical acids, chlor alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, and chlorinated solvents, as well as industrial alchols, ketones, amines, oleochemicals, intermediates, olefines, phosphates, fertilizers, monomers, and chemicals. The company's pharmaceutical products are used by pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. It also trades in industrial solvents and chemicals. The company was incorporated in 1990 and is headquartered in Mumbai, India.

Corporate governance

AAREY DRUGS & PHARMACEUTICALS’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.